Comment on Ramai et al. Risk of Hepatocellular Carcinoma in Patients with Porphyria: A Systematic Review. Cancers 2022, 14, 2947

Cancers (Basel). 2023 Jan 28;15(3):795. doi: 10.3390/cancers15030795.

Mattias Lissing^{1

2}, Daphne Vassiliou^{3

4

5}, Pauline Harper^{4

6}, Eliane Sardh^{3

4

5}, Staffan Wahlin^{1

2}

¹ Hepatology Division, Department of Upper GI Diseases, Karolinska University Hospital, 17164 Stockholm, Sweden.
² Department of Medicine, Huddinge, Karolinska Institutet, 14186 Stockholm, Sweden.
³ Department of Endocrinology, Karolinska University Hospital, 17164 Stockholm, Sweden.
⁴ Centre for Inherited Metabolic Diseases (CMMS), Porphyria Centre Sweden, Karolinska University Hospital, 17164 Stockholm, Sweden.
⁵ Department of Molecular Medicine and Surgery, Karolinska Institutet, 14186 Stockholm, Sweden.
⁶ Department of Medical Biochemistry and Biophysics, Karolinska Institutet, 14186 Stockholm, Sweden.

Abstract

We read with interest this review by Ramai et al. [...].

This research received no external funding.